Bayforest Capital LTD Novartis Ag Transaction History
Bayforest Capital LTD
- $79.8 Billion
- Q4 2024
A detailed history of Bayforest Capital LTD transactions in Novartis Ag stock. As of the latest transaction made, Bayforest Capital LTD holds 3,275 shares of NVS stock, worth $345,283. This represents 0.4% of its overall portfolio holdings.
Number of Shares
3,275Holding current value
$345,283% of portfolio
0.4%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,462Shares Held
132MCall Options Held
1.33MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.29 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.16 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$863 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$724 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$588 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $227B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...